This week in transparency news: July 21 – July 27, 2018
Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a weekly round-up of some of the key stories surrounding disclosures…
Topic
Regulatory Compliance
This week in transparency news: July 14 – July 20, 2018
Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a weekly round-up of some of the key stories surrounding disclosures…
This week in transparency news: June 30 – July 6, 2018
Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure will be bringing a weekly round-up of some of the key stories…
Good Pharma Scorecard: Improvements Seen in Clinical Trial Transparency Compliance
Bioethics International recently published their second, long-promised Good Pharma Scorecard, a ranking of large biopharmaceutical companies’ compliance with disclosing data for new medicines to public registries, in BMJ…
Research Organizations Commit to Full Transparency
Another significant advancement in clinical trial transparency was announced on May 18. In a joint statement released on the World Health Organization (WHO) website, 12 of the world’s…
Major Legal Ruling Announced in Transparency Reporting: Agencies Want to See More Data Quicker (& Data for Non-Approved Drugs Too!)
Releasing the details and results of clinical trials to the public has long been a critical ethical issue facing the pharmaceutical industry. How much information should be disclosed?…
Inconsistent Clinical Trial Disclosure and Lack of Compliance Across Big Pharma
Both the Food and Drug Administration (FDA) and independent research groups have highlighted the lack of compliance with laws (2007 FDA Amendments Act) mandating that clinical trial data…
Clinical Trial Disclosure: More “FDA” Needed in Past and Present Acts
Federal mandates calling for transparency of clinical trial information have been in place in the United States since 1997, but a recent move will finally give the current…
Clinical Disclosure Reporting: Are You Prepared to Meet the Expanding Requirements?
A group of House Democrats led by Congressman Edward Markey (D-Mass.) on Aug. 2, 2012 introduced the Trial and Experimental Studies Transparency (TEST) Act of 2012 (H.R. 6272),…